Cancer Registry On-Boarding Process
Click the steps below for more information.
- Stage 2: Complete Steps 1-6
- Step 1: Registration
Eligible Provider or Eligible Hospital notifies ADH of interest in submitting cancer data for Meaningful Use.
Complete the Cancer Registry registration process through the Meaningful Use Registration and Communications System (MURCS).
Note: Completion of this step assumes the data submitter has acquired and implemented a certified health IT product capable of producing an HL7 Clinical Document Architecture (CDA) cancer data message.
Proceed to Step 2: Pre-Testing.
- Step 2: Pre-Testing
Validate test messages using the CDC’s CDA Validation Plus tool.
Request a copy of the CDA Validation Plus tool by sending an email to firstname.lastname@example.org.
Follow these steps to process a XML test message:
- Create a XML test message from your certified EHR. Name the file NPI_Validation.xml (NPI being the NPI of the testing facility/provider).
- Validate the test message using the Validation Plus tool. (A training manual is provided with the Validation Plus download.)
- Save the validation results to a PDF. Name the file NPI_Validation.pdf (NPI being the NPI of the testing facility/provider).
Note: The CDA Validation Plus tool validates XML documents created by EHR technology against the structure defined by the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, and all included and referenced standards, specifications, and guidelines. The tool is intended for certifying 2014 Edition Meaningful Use EHR technology.
Proceed to Step 3: Testing.
- Step 3: Testing
Eligible Provider or Eligible Hospital submits Cancer Registry test message to ADH.
- Upload a test message into MURCS, and include Cancer Registry validation reports that indicate the test message is error-free.
- Uploading an HL7 2.5.1 Validation Report into MURCS.
Questions: Please contact Cancer Registry.
Email is not a secure mechanism of data transfer. Do not submit test messages containing personally identifiable health information through email. ADH reviews the messages, and ensures that they meet standards specified for Meaningful Use. Once the review is complete, ADH provides communication about the outcome of testing that can be used for attestation purposes.
Proceed to Step 4: In Queue.
- Step 4: In Queue
Eligible Provider placed on a waiting list for ongoing submission and additional validation.
Eligible hospitals or professionals who have successfully submitted qualifying test messages are placed into the queue. ADH Program Coordinators will notify eligible providers in order of registration.
We anticipate the length of the queue will grow as Meaningful Use progresses. To improve timeliness, please provide ADH with Cancer Registry validation reports and test messages as early as possible in your attestation process.
Once an eligible hospital or professional reaches the front of the queue, they will be notified by an ADH program coordinator when it is time to move on to Step 5: Validation.
- Step 5: Validation
Eligible Provider establishes ongoing electronic cancer data feed to ADH and work with Cancer Registry Coordinator for data validation.
Select a data transport mechanism for ongoing submission of cancer data.
- Arkansas Department of Health supports the following transport options: HTTPS Web Service (preferred), Virtual Private Network (VPN), Secure File Transport Protocol (SFTP) and the Arkansas State Health Alliance for Records Exchange (SHARE).
HTTPS Web Service
- *** Web Service to include all other public health objectives within ADH. This point of access is now available for Cancer. ***
- VPN stands for Virtual Private Network. A VPN allows you to create a secure channel of communication (a.k.a. a "tunnel") over a public network such as the Internet. Security is provided through authentication, to ensure that the entity connecting is authorized, and through encryption, to protect the data in transit.
- The Arkansas HIE is implemented
Set up a transport mechanism.. Request WSDL and client certificate from your interface coordinator or send an email to ADH.CANCER.MU@arkansas.gov
Transmit a test message via the web service.
Begin ongoing submission and participate in validation activities.
Go to Step 6: Production
- Step 6: Production
Eligible Provider reports via cancer data electronic feed and participates in periodic quality assurance activities.
Continue ongoing submission of cancer data to public health.
If public health identifies a need to follow-up on data indicating an event of potential public health concern, they will contact data providers.
Eligible hospitals and professionals will be required to participate in periodic quality assurance checks to ensure accuracy of reporting. Arkansas Department of Health program coordinators will contact data providers to schedule these activitieses.
Do you want to know more about Meaningful Use activities at the Arkansas Department of Health? Please visit our Meaningful Use page.
Questions? Please contact Central Cancer Registry: ADH.CANCER.MU@arkansas.gov